Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (41-50 of 173) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|February 6, 2016
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 monthsMatthew A Lunning, Jocelyn C Migliacci, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodiesParastoo B Dahi, Jonathan Barone, Sean M Devlin, et al.
Transplantation and Cellular Therapy|May 15, 2021
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected GraftsReuben P Jacob, Jessica Flynn, Sean M Devlin, et al.
Leukemia & Lymphoma|June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplantIzaskun Ceberio, Sean M Devlin, Craig Sauter, et al.
Leukemia & Lymphoma|December 3, 2016
Proteomic profiling in plasma cell disorders: a feasibility studySham Mailankody, Sean M Devlin, Neha Korde, et al.
British Journal of Haematology|June 27, 2015
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer CenterJustin M Watts, Ashwin Kishtagari, Meier Hsu, et al.
Leukemia Research|August 30, 2016
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemiaJustin M Watts, Bogdan Dumitriu, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple MyelomaEric Smith, Sean M Devlin, Satyajit Kosuri, et al.
Bone Marrow Transplantation|March 11, 2018
Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experienceRichard J Lin, Armin Shahrokni, Parastoo B Dahi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2020
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood TransplantationVictoria Gutgarts, Insara Jaffer Sathick, Junting Zheng, et al.
Pageof 18

Showing results (41-50 of 173) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|February 6, 2016
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 monthsMatthew A Lunning, Jocelyn C Migliacci, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodiesParastoo B Dahi, Jonathan Barone, Sean M Devlin, et al.
Transplantation and Cellular Therapy|May 15, 2021
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected GraftsReuben P Jacob, Jessica Flynn, Sean M Devlin, et al.
Leukemia & Lymphoma|June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplantIzaskun Ceberio, Sean M Devlin, Craig Sauter, et al.
Leukemia & Lymphoma|December 3, 2016
Proteomic profiling in plasma cell disorders: a feasibility studySham Mailankody, Sean M Devlin, Neha Korde, et al.
British Journal of Haematology|June 27, 2015
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer CenterJustin M Watts, Ashwin Kishtagari, Meier Hsu, et al.
Leukemia Research|August 30, 2016
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemiaJustin M Watts, Bogdan Dumitriu, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple MyelomaEric Smith, Sean M Devlin, Satyajit Kosuri, et al.
Bone Marrow Transplantation|March 11, 2018
Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experienceRichard J Lin, Armin Shahrokni, Parastoo B Dahi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2020
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood TransplantationVictoria Gutgarts, Insara Jaffer Sathick, Junting Zheng, et al.
Pageof 18